EUROSCOP, ISOLDE and the Copenhagen city lung study

Thorax

Volumn 54, Issue 4, 1999, Pages 287-288

  Burge, P Sherwood ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE;

BONE ATROPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL STUDY; DENMARK; DYSPHONIA; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; POPULATION RESEARCH; PRIORITY JOURNAL; SKIN DEFECT; SMOKING; STATISTICAL ANALYSIS; THRUSH; VITAL CAPACITY;

EID: 0033062492     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.4.287     Document Type: Editorial

References (4)

1. 1. The Lung Health Study. JAMA 1994;272:1497-505.
2. 1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996;153:1530-5.
3. 3 Paggiaro PL, Dahle R, Bakran I, et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group (see comments). Lancet 1998;351:773-80; 1968 (erratum).
4. 4 van Grunsven PM, van Schayck CP, Derenne JP, et al. Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Thorax 1999;54:7-14.